Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Choriogonadotropin alfa 250micrograms injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing choriogonadotropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Choriogonadotropin alfa 250micrograms injection powder for reconstitution+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotrophin 1500iu injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotrophin 2000iu injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
choriogonadotropine alfa 5000 UI, ampoule de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chorionic gonadotrophin 10,000iu injection (pdr for recon)+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choriogonadotropin alfa 250micrograms injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choriogonadotropin alfa 10,000iu powder for conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choriogonadotropin alfa 1500iu powder for conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choriogonadotropin alfa 5000iu powder for conventional release solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely choriogonadotropin alfa 250 microgram/0.5 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely choriogonadotropin alfa 250 microgram/0.5 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Choriogonadotropin alfa-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only choriogonadotropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Choriogonadotropin alfa only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely choriogonadotropin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely choriogonadotropin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Choriogonadotropin alfa (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |